Virtual Brunch 2020

Ask the Dr. Panel

Is immunotherapy used for ovarian cancer and has it been successful?

Dr. Barroilhet

Dr. Barroilhet is the Dolores A. Buchler, MD, Faculty Fellow in Gynecologic Oncology and an Assistant Professor of Medicine at the University of Wisconsin School of Medicine and Public Health. She completed her four-year residency in obstetrics and gynecology at University of North Carolina-Chapel Hill. After finishing her residency in 2009, she began her three-year clinical and research fellowship in gynecologic oncology at Brigham and Women's Hospital in Boston, Massachusetts. She holds board certification in Obstetrics and Gynecology. Find Out More>>>

Are Maintenance drugs considered part of "Standard of Care"?

Dr. Bishop

Dr. Bishop joined the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, at the Medical College of Wisconsin as an Assistant Professor in October, 2013. She received her Doctor of Medicine from the University of Wisconsin School of Medicine and Public Health in 2006. She subsequently went on to complete her residency in Obstetrics and Gynecology at the University of Chicago in Chicago, Illinois. After her four year residency, she continued her training in the subspecialty of Gynecology Oncology. Dr. Bishop completed a three year fellowship in Gynecology Oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. Find Out More>>>

What is the risk of people not in active treatment and the risk of COVID - 19?  

Dr. Dickson

With survivorship as her main goal, Elizabeth Dickson, MD, believes in a team approach to cancer care, incorporating research, integrative medicine, and state of the art techniques to treat not only the patient's disease, but also support her whole being through cancer

treatment and beyond. Dr. Dickson is trained in minimally invasive approaches, including traditional laparoscopy and robotic surgery. She has advanced research training and is committed to continuing research, in order to better care for women with cancer. Find Out More>>>

How common is ovarian cancer with lymph node recurrence? What is the recommended treatment?

Dr. Schink

Julian Schink, MD, is the Chief Medical Officer of Cancer Treatment Centers of America® (CTCA). In addition, Dr. Schink serves as Chief of Gynecologic Oncology for CTCA®, Medical Director of Gynecologic and Medical Oncology and Senior Vice President of Clinical Affairs for CTCA Chicago. He brings more than 25 years of oncology experience to CTCA, joining the national cancer care network in May 2017. Find Out More>>>

Do they agree that sugar feeds cancer? That cutting down on carbs and sugar can starve cancer cells?

Dr. Stevens

I am often the first person a patient will meet after a diagnosis or suspicion of a gynecologic cancer. My role includes leading the surgical team and assisting in treatment planning and surveillance, while comforting the patient at one of the most stressful times of her life. I believe in comprehensive, personalized care for each patient, which includes nurse navigation, nutrition, social work, supportive care, physical therapy as well as experienced medical oncologists, radiation oncologists, physician assistants, nurse practitioners and access to clinical trials on the local and national level.. Find Out More>>>

  • Facebook - Grey Circle
  • Twitter - Grey Circle
  • Instagram - Grey Circle

©2000 Wisconsin Ovarian Cancer Alliance. All Rights Reserved.  The Wisconsin Ovarian Cancer Alliance is a 501(c)(3) tax-exempt organization.